How Flat Stop-Loss Deductibles Turn 12% Claims Trend Into 30% Carrier Exposure Growth

When a self-funded plan's underlying medical trend runs 12% but its specific stop-loss deductible stays anchored at $200,000, the carrier's expected reimbursement grows faster than 12%, because a larger share of every large claim clears the fixed threshold. Segal's Q3 2026 report, built on 225 self-funded plans, found stop-loss premiums rose 12.7% for plans that held deductibles flat, versus 11.5% for all plans (Segal, July 2026).

The Leverage Mechanism: A Fixed Floor Under a Moving Distribution

Stop-loss reimbursement is a limited expected value problem, not a scaled-mean problem. Define the limited expected value at deductible D as LEV(D) = E[X ∧ D] = ∫₀^D [1 − F(x)] dx, where F is the cumulative distribution of individual claim costs. The expected stop-loss reimbursement per claim is then E[X] − E[X ∧ D], and the excess loss factor, ELF(D) = (E[X] − E[X ∧ D]) / E[X], is the fraction of total expected claim dollars that falls to the carrier above the deductible.

Apply a severity trend of t and claims shift to t·X, but D does not move with them; plan sponsors rarely reset a specific deductible mid-contract, and many hold it flat across multiple renewals to protect budget stability. The new expected excess loss becomes t·E[X] − E[t·X ∧ D]. Because E[t·X ∧ D] grows more slowly than t·E[X ∧ D] once D sits inside the trended distribution's mass, the excess loss grows faster than t. The leveraged trend factor, LTF = (t·E[X] − E[t·X ∧ D]) / (E[X] − E[X ∧ D]), exceeds t whenever D is greater than zero. That single inequality is the entire mechanism plan sponsors are paying for when they hold a deductible flat through a high-trend renewal cycle.

A Worked Illustration: Convexity Gets Worse Near the Deductible

HM Insurance Group's leveraged trend illustration makes the mechanism concrete. A $150,000 claim against a $100,000 specific deductible leaves the carrier holding $50,000. Apply 10% first-dollar trend and the same claim becomes $165,000, pushing the carrier's exposure to $65,000, a 30% increase in carrier liability from a 10% increase in claim cost (HM Insurance Group, Leveraged Trend). Berkley Accident and Health frames the same arithmetic and the same conclusion: a lower deductible means the carrier absorbs more claims, more often, and prices accordingly, while raising the deductible offsets leveraged trend by shifting more of the risk back to the employer (Berkley Accident and Health, Understanding Leveraged Trend).

The convexity sharpens as claims sit closer to the deductible. A $120,000 claim against that same $100,000 deductible starts at $20,000 of carrier exposure. The identical 10% trend lifts the claim to $132,000 and carrier exposure to $32,000, a 60% jump on the same 10% underlying trend (Benefits Blake, "Why Your Stop-Loss Premium Jumps 30% When Claims Only Grew 10%"). Claims that barely clear the deductible carry the highest leverage, because a proportionally small dollar shift in the claim moves a proportionally large share of it across the threshold. That is the derivative pricing actuaries need: not the average trend across the whole claim, but the local slope of the excess-loss function evaluated at D.

Modeling the Full Distribution: The Lognormal Excess Loss Factor

A single claim example shows the mechanism; pricing a book requires fitting a severity curve to it. Stop-loss actuaries typically fit large claims above roughly $50,000 (reducing reporting-lag noise from smaller, still-developing claims) to a lognormal or single-parameter Pareto distribution, then recompute LEVs at the proposed deductible under a trended parameter set. Using a lognormal with mean $150,000 and σ = 1.2, a level broadly consistent with the heavy-tailed severity common in stop-loss experience, a 12% trend applied against a $200,000 specific deductible moves the expected excess loss from roughly $56,000 to roughly $68,000 per claim in the tail, an increase of about 21%, or roughly 1.8 times the 12% underlying trend rate. That 1.5x to 2x range of amplification is typical for specific deductibles in the $150,000 to $300,000 band; it widens further as the deductible sits farther out in the tail relative to the mean, and narrows as the deductible moves closer to the body of the distribution.

The practical implication is that a pricing actuary who trends the mean claim cost by 12% and applies that same 12% to the prior year's stop-loss rate has under-priced the renewal, potentially by a material margin, because the correct multiplier is not the trend rate itself but the trend rate evaluated through the convex excess-loss function at the specific deductible in force.

What Segal's Q3 2026 Data Confirms in the Market

Segal's SHAPE (Segal Health Actuarial and Plan Experience) data warehouse, drawing on 225 self-funded plans nationwide, documents the leverage mechanism showing up as realized premium. The number of claimants with seven-figure claims has grown an average of 25% per year over the last four years (Segal, July 2026), a frequency trend independent of the leveraged trend effect but compounding it, since more claims crossing into seven figures means more claims sitting deep in the convex region of the excess-loss curve. Segal recommends aggregating specific deductibles and run-out extensions as the primary levers plan sponsors have to manage the premium consequence, precisely because raising the effective attachment point is the direct offset to leveraged trend identified in the LTF formula above.

The 1.2-percentage-point gap between the 12.7% flat-deductible increase and the 11.5% blended increase is itself a pricing input: it is the market's realized price of allowing deductible erosion, applied across a 225-plan sample rather than a single hypothetical illustration. Separately, Aegis Risk's most recent published survey, covering 1,268 stop-loss policies and more than 1.2 million covered employees representing over $1.2 billion in annual premium, recorded single-year increases in the 8.8% to 10% range for 2025 (Aegis Risk, 2025 Medical Stop-Loss Premium Survey), a lower baseline than Segal's 2026 figures that is consistent with trend accelerating into the current renewal cycle.

Pricing the Aggregating Specific Deductible

An aggregating specific deductible (ASD) is a corridor a plan sponsor accumulates across all large claims before stop-loss reimbursement begins in that layer, priced as the expected loss in the band between the specific deductible D and D plus the ASD limit, using the same fitted severity curve at two attachment points. The credit is E[(X − D)⁺ − (X − D − ASD)⁺], which reduces algebraically to E[X ∧ (D + ASD)] − E[X ∧ D].

Continuing the lognormal illustration above (mean $150,000, σ = 1.2, untrended for clarity), a pure $200,000 specific deductible leaves the carrier with an expected excess loss near $56,000 per claim. Layer a $100,000 ASD on top, so reimbursement in the $200,000 to $300,000 corridor requires the plan to first accumulate $100,000 of aggregated large-claim exposure, and the carrier's expected obligation in that corridor comes to roughly $15,500 per claim, dropping its total expected excess loss to about $40,500. That corridor value is the basis for the rate credit: the employer retains roughly $15,500 of expected exposure per claim in exchange for a premium reduction proportional to that same figure, before carrier margin and expense loads. The trade-off is concrete enough for a plan sponsor to evaluate directly against its own claims history rather than as an abstract deductible-level decision.

Run-Out Extensions, Credibility, and Deductible Adequacy

Specialty drug and post-acute claims frequently adjudicate months after the incurred date, and Segal's report recommends that plans on a shorter run-out basis move from a 12/15 policy, where claims incurred over 12 months are paid within 3 months after expiration, to at least a 12/18 or 12/24 structure (Segal, July 2026). Actuaries price that extension as an explicit IBNR load, built from historical payment-lag distributions segmented by claim type, since specialty pharmacy and cell and gene therapy claims carry materially longer development tails than routine inpatient claims.

For small and mid-size groups, typically in the 250 to 1,000 employee range, large-claim experience above any specific deductible lacks full credibility on its own. A Buhlmann-Straub credibility approach, weighting each group's own large-claim loss ratio against a pooled industry factor by exposure measured in covered-member-months above the deductible, is the standard treatment rather than pricing the group entirely off its own thin claims history. Plan actuaries evaluating deductible adequacy at renewal should compare the proposed specific deductible against the 80th percentile of the group's own multi-year large-claim history; a deductible set below that percentile leaves the carrier effectively covering claims that fall within the plan's own expected shock-loss range, which is exactly the condition under which the leveraged trend penalty documented above runs highest.

Why This Matters

Leveraged trend is not a stop-loss carrier pricing quirk; it is a direct, formula-derived consequence of holding a fixed attachment point against a distribution that is shifting under it, and Segal's 225-plan dataset shows the effect is now large enough to separate premium outcomes by more than a point. Pricing actuaries who model only the shift in mean claim cost, rather than the trended excess-loss function at the deductible actually in force, will systematically under-price renewals for plans that keep deductibles flat. Plan sponsor advisors who treat deductible level, aggregating layers, and run-out period as three independent negotiating points rather than three coupled levers on the same excess-loss curve are leaving pricing precision on the table at exactly the renewal cycle where the seven-figure claimant count is growing fastest.